OncoMed Pharmaceuticals Inc Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
OncoMed Pharmaceuticals Inc reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $86.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2019-03-07
- OncoMed Pharmaceuticals Inc unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2018 was $86.00K.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|
| 2018-12-31 | $86.00K 10-K · filed 2019-03-07 |